Related Experiment Video
Updated: Jun 7, 2025
Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Bioinformatics analysis of key genes and potential therapeutic agents for vascular calcification in chronic kidney
Guojie Ye1,2, Tengfei Liu1,2, Chunhua Ding1,2
1Cardiac Department, Aerospace Center Hospital, Beijing, China.
Abstract:
Vascular calcification is a common complication of chronic kidney disease (CKD). The molecular mechanisms underlying this condition and the efficacy of potential treatments remain unclear. Bioinformatic methods were employed to analyze gene ontology (GO) annotations and pathway enrichments. Subsequently, an analysis of potential therapeutic agents for vascular calcification in CKD was performed. A total of 76 common genes, 181 enriched GO annotations-comprising 153 biological processes, 10 cellular components, and 18 molecular functions-41 KEGG pathways, 13 REACTOME pathways, and 3 BIOCARTA pathways were identified. Five key genes (PSMC5, TNFSF11, TNFRSF11A, TNFRSF12A, and ICAM1) were isolated. Most notably, the top five potential therapeutic drugs-ENAVATUZUMAB, DENOSUMAB, ALICAFORSEN, BI-505, and ENLIMOMAB PEGOL-were identified for vascular calcification in CKD. However, further molecular biological experiments are required to confirm these findings.
Insights
Vascular calcification in chronic kidney disease (CKD) involves complex molecular mechanisms. This study identifies key genes and potential drugs like Enavatuzumab for treating this common CKD complication.
Area of Science:
- Biochemistry
- Genetics
- Pharmacology
Background:
- Vascular calcification is a frequent complication in chronic kidney disease (CKD).
- The precise molecular underpinnings and effective therapeutic strategies for vascular calcification in CKD are not fully understood.
Purpose of the Study:
- To elucidate the molecular mechanisms of vascular calcification in CKD using bioinformatic analysis.
- To identify potential therapeutic agents for managing vascular calcification in CKD patients.
Main Methods:
- Bioinformatic analysis of gene ontology (GO) annotations and pathway enrichments.
- Identification of common genes, enriched GO terms, and signaling pathways (KEGG, REACTOME, BIOCARTA).
- Screening for potential therapeutic drugs targeting identified molecular pathways.
Main Results:
- Identified 76 common genes, 181 enriched GO annotations, and multiple enriched pathways.
- Isolated five key genes: PSMC5, TNFSF11, TNFRSF11A, TNFRSF12A, and ICAM1.
- Discovered five potential therapeutic drugs: ENAVATUZUMAB, DENOSUMAB, ALICAFORSEN, BI-505, and ENLIMOMAB PEGOL.
Conclusions:
- The study provides a comprehensive bioinformatic analysis of vascular calcification in CKD.
- Key genes and potential therapeutic targets have been identified, offering new avenues for treatment.
- Further experimental validation is necessary to confirm the therapeutic efficacy of the identified agents.
Related Concept Videos
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
01:24Regulation of Angiogenesis and Blood Supply